# Imaging Study in Metastatic Clear Cell RCC.

> **NCT07671417** · EARLY_PHASE1 · RECRUITING · sponsor: **RayzeBio, Inc.** · enrollment: 10 (estimated)

## Conditions studied

- Metastatic Clear Cell Renal Cell Carcinoma

## Interventions

- **DIAGNOSTIC_TEST:** RYZ512

## Key facts

- **NCT ID:** NCT07671417
- **Lead sponsor:** RayzeBio, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-15
- **Primary completion:** 2027-01
- **Final completion:** 2027-02
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07671417

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07671417, "Imaging Study in Metastatic Clear Cell RCC.". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07671417. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*